Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants

Detalles Bibliográficos
Autores principales: Su, Shan, Shao, Yiming, Jiang, Shibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971202/
https://www.ncbi.nlm.nih.gov/pubmed/33635184
http://dx.doi.org/10.1080/22221751.2021.1896956
_version_ 1783666568660516864
author Su, Shan
Shao, Yiming
Jiang, Shibo
author_facet Su, Shan
Shao, Yiming
Jiang, Shibo
author_sort Su, Shan
collection PubMed
description
format Online
Article
Text
id pubmed-7971202
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-79712022021-03-31 Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants Su, Shan Shao, Yiming Jiang, Shibo Emerg Microbes Infect Commentary Taylor & Francis 2021-03-13 /pmc/articles/PMC7971202/ /pubmed/33635184 http://dx.doi.org/10.1080/22221751.2021.1896956 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Su, Shan
Shao, Yiming
Jiang, Shibo
Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants
title Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants
title_full Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants
title_fullStr Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants
title_full_unstemmed Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants
title_short Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants
title_sort human challenge trials to assess the efficacy of currently approved covid-19 vaccines against sars-cov-2 variants
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971202/
https://www.ncbi.nlm.nih.gov/pubmed/33635184
http://dx.doi.org/10.1080/22221751.2021.1896956
work_keys_str_mv AT sushan humanchallengetrialstoassesstheefficacyofcurrentlyapprovedcovid19vaccinesagainstsarscov2variants
AT shaoyiming humanchallengetrialstoassesstheefficacyofcurrentlyapprovedcovid19vaccinesagainstsarscov2variants
AT jiangshibo humanchallengetrialstoassesstheefficacyofcurrentlyapprovedcovid19vaccinesagainstsarscov2variants

Ejemplares similares